Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Injective (INJ) vs Lisk (LSK) Price & Performance

InjectiveTrade
LiskTrade

Price performance (Past 24H)

Key statistics

Injective vs Lisk — how do they compare? Injective trades at Rp92,698 (market cap Rp9,18T, Rp1,72T 24h volume), while Lisk trades at Rp1,579 (market cap Rp347,43M, Rp42,22M 24h volume). The key difference: Injective is far larger — about 26422.6× Lisk's market cap, and Lisk's supply is capped (221,2M / 400M LSK (56%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Lisk for 24 Days on average.

INJLSK
Market Cap
Rp9,18TRp347,43M
Volume (24h)
Rp1,72TRp42,22M
Circulating Supply
100M INJ221,2M / 400M LSK (56%)
Typical Hold Time
36 Days24 Days

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Injective

Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.

Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.

Lisk

LSK currently trades at Rp1,580 with neutral technical signals across oscillators and mixed moving averages. The token shows moderate network activity with 56% of max supply in circulation and average hold time of 24 days. Current price sits between support at Rp1,575 and resistance at Rp1,616, indicating consolidation phase with no major protocol updates recently reported.

Outlook remains neutral with key opportunity in potential breakout above Rp1,616 resistance. Major risks include typical crypto volatility and limited recent ecosystem developments. Investors should monitor trading volume patterns and broader market sentiment for directional cues.

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INJ
29% Buy71% Sell
Avg holding period · 36 Days
LSK
44% Buy56% Sell
Avg holding period · 24 Days

Top news

Latest headlines on both assets

About Injective

Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.

Read more on INJ

About Lisk

Lisk (LSK) is a Layer 2 blockchain designed to boost Web3 adoption in emerging markets through Ethereum integration. It offers a developer-friendly SDK for building blockchain applications and supports scalable sidechains connected to its mainchain for efficient development.

Read more on LSK